Table 4.
Current clinical trials on exosomes in lung cancer
| Title | Status | Conditions | Interventions |
|---|---|---|---|
| Combined diagnosis of CT and exosome in early lung cancer | Not yet recruiting | Early lung cancer | Procedure: surgery |
| Serum exosomal long noncoding RNAs potential biomarkers for lung cancer diagnosis | Recruiting | Lung cancer | Diagnostic test: collect samples |
| Clinical research for the consistency analysis of PD-L1 in lung cancer tissue and plasma exosome before and after radiotherapy | Unknown | NSCLC | Radiation: radiotherapy |
| Dynamic monitoring circulating tumor DNA in surgical patients with lung cancer | Recruiting | Lung cancer | Other: blood samples |
| Detection of circulating biomarkers of immunogenic cell death | Active, not recruiting | NSCLC | Other: blood samples |
| Circulating exosome RNA in lung metastases of primary high grade | Recruiting | Lung metastases | |
| Osteosarcoma | Other: blood samples | ||
| Olmutinib trial in T790 M (+) NSCLC patients detected by liquid biopsy using BALF extracellular vesicular DNA | Active, not recruiting | NSCLC | Drug: olmutinib |
| Detection of either the EML4-ALK gene rearrangements or the T790 M EGFR mutation in the plasma of advanced NSCLC patients | Active, not recruiting | Carcinoma | |
| NSCLC | Other: blood samples | ||
| Pilot study with the aim to quantify a stress protein in the blood and in the urine for the monitoring and early diagnosis of malignant solid tumor | Recruiting | Cancer | Other: blood samples |
| Other: urine samples |